Delivery Order SPE2DB20D9331-SPE2DB25FL1L2
- Not listed
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $1,041.56 to DMS Pharmaceutical Group Inc. for the supply of Mirena 52 mg systems. This contract, issued on July 14, 2025, with an ultimate completion date of August 4, 2025, represents a firm fixed-price delivery order with no set-aside designation. DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler headquartered in Park Ridge, Illinois, will perform this delivery order at its Park Ridge...
- The Defense Logistics Agency (DLA) awarded a firm fixed-price delivery order valued at $1,041.56 to DMS Pharmaceutical Group Inc. for 52 mg Mirena systems, with an ultimate completion date of October 7, 2025. DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler headquartered in Park Ridge, Illinois, was selected without a set-aside designation. This delivery order represents a single transaction under the company's larger Indefinite Delivery Contract (IDC) with...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $10,415.40 to DMS Pharmaceutical Group Inc. on July 28, 2025, for the supply of Mirena 52 mg systems. The award, which carries an ultimate completion date of August 18, 2025, utilizes a firm fixed-price contract type with no set-aside designation. DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, will perform this delivery order at its Illinois facility. The...
- The Defense Logistics Agency (DLA) awarded a $15,623.10 delivery order to DMS Pharmaceutical Group Inc. for the supply of Mirena 52 mg systems, effective September 17, 2025, with an ultimate completion date of October 8, 2025. The contract utilizes firm fixed-price pricing with no set-aside designation. DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler headquartered in Park Ridge, Illinois, will perform the work at its primary location. This delivery order...
- The Defense Logistics Agency (DLA) awarded a firm fixed-price delivery order valued at $26,038.50 to DMS Pharmaceutical Group Inc. for Mirena 52 mg systems. DMS Pharmaceutical Group, a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, was selected without a set-aside designation. The delivery order is scheduled for ultimate completion on October 8, 2025, with performance taking place at the contractor's Park Ridge facility. Mirena is a hormonal intrauterine...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $13,019.25 to DMS Pharmaceutical Group Inc. for Mirena 52 mg systems, with an ultimate completion date of September 26, 2025. This firm fixed-price delivery order represents a purchase under DLA's larger Indefinite Delivery Contract (IDC) with DMS Pharmaceutical Group, valued at approximately $500 million and valid through November 2026. The award carries no set-aside designation, allowing the woman-owned small business...
- This firm-fixed-price delivery order was awarded to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The $2,960 contract is for the supply of Mirena 52 mg systems, a type of intrauterine contraceptive device. It was awarded by the Defense Logistics Agency (DLA), a defense agency, and has an ultimate completion date of June 6, 2024. DMS Pharmaceutical Group holds a significant $499,999,999 indefinite delivery contract (IDC)...
- The U.S. Defense Logistics Agency (DLA) awarded a $11,619.20 firm fixed-price delivery order contract to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract is for the delivery of Mirena 52 mg systems, a contraceptive product, with a completion date of September 15, 2023. This delivery order is issued under DMS Pharmaceutical Group's single-award, indefinite delivery contract (IDC) with DLA valued at up to...
- The Defense Logistics Agency (DLA) awarded a firm fixed-price delivery order valued at $4,166.24 to DMS Pharmaceutical Group Inc. for the supply of Mirena 52 mg systems. The award, issued on August 1, 2025, with an ultimate completion date of August 22, 2025, represents a delivery order under DMS Pharmaceutical Group's larger single-award Indefinite Delivery Contract (IDC) with DLA valued at approximately $500 million through November 2026. The delivery order carries no set-aside designation,...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $7,811.55 to DMS Pharmaceutical Group Inc. for the supply of Mirena 52 mg systems, with an ultimate completion date of August 11, 2025. This firm fixed-price delivery order, issued on July 21, 2025, carries no set-aside designation. DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, will perform the work at its facility in Park Ridge, IL. The company leverages...
- SPE2DB20D9331Indefinite Delivery Contract
- SPE2DB20D9331-SPE2DB25FL1L2Delivery Order
The Defense Logistics Agency (DLA) awarded a delivery order valued at $31,246.20 to DMS Pharmaceutical Group Inc. for 52 mg Mirena systems on June 17, 2025, with an ultimate completion date of July 10, 2025. This firm fixed-price delivery order was issued without a set-aside designation to the woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. Mirena is a long-acting reversible contraceptive device, consistent with DMS Pharmaceutical Group's portfolio of pharmaceutical and medical supply products delivered to federal healthcare facilities. This delivery order is issued under DMS Pharmaceutical Group's larger Indefinite Delivery Contract with the DLA's SPE2DB program, valued at $499,999,999 and valid through November 2026. The IDC enables the DLA to procure a comprehensive range of pharmaceutical items supporting medical supply needs across Department of Defense healthcare facilities worldwide, including prescription medications, biologics, vaccines, and medical consumables. As a key pharmaceutical supplier within the federal supply chain since 2001, DMS Pharmaceutical Group leverages its woman-owned small business status to compete effectively for delivery orders covering diverse medical products spanning oncology treatments, specialty injections, contraceptive devices, and other critical healthcare supplies.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $31.2k | 6/17/25 |